Danaher DHR · USD
Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States
S&P 500
235.14
+2.12%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Danaher
From its filings with the US Securities and Exchange Commission
Danaher is based in Washington, Washington, DC and is incorporated in Delaware. Its shares trade on NYSE under the ticker DHR. It is a member of the S&P 500. The SEC classifies its business as industrial instruments for measurement, display, and control. In the fiscal year to 31 December 2025, it reported revenue of $24.57bn and net income of $3.61bn. At that date it held total assets of $83.46bn and shareholders' equity of $52.53bn. By business, Recurring brought in 81.9% of revenue, followed by Nonrecurring at 18.1%. By region, North America accounted for 42.2%, followed by High-growth markets at 28.6% and Western Europe at 24.2%.
Danaher is a global science and technology innovator committed to accelerating the power of science and technology to improve human health. Danaher is comprised of more than 15 operating companies with leadership positions in the biotechnology, life sciences and diagnostics sectors, organized under three segments (Biotechnology, Life Sciences and Diagnostics). United by the DANAHER BUSINESS SYSTEM (“DBS”), our businesses are also typically characterized by a high level of products and services that are sold on a recurring basis, primarily through a direct sales model and to a geographically diverse customer base. Our business’ research and development, manufacturing, sales, distribution, service and administrative facilities are located in approximately 50 countries.
Danaher measures its progress against these strategic priorities over the long-term based primarily on financial metrics relating to revenue growth, profitability, cash flow and capital returns, as well as certain non-financial metrics. To further the strategic objectives set forth above, the Company also acquires businesses and makes investments that either complement its existing business portfolio or expand its portfolio into new markets that the Company deems attractive.
Quoted from its 10-K, filed 24 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 10 Dec 1969
- Employees
- 60,000
- Website
- danaher.com ↗
- Head office
- 2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC, 20037-1701
- Incorporated in
- DE
- Classification
- Industrial Instruments For Measurement, Display, and Control
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Steven RalesChairman of the Board, since 1983
- Mr. Rainer BlairPresident, Chief Executive Officer, Director, since 2014$22.1m
- Mr. Matthew McgrewChief Financial Officer, Executive Vice President$7.5m
- Mr. Mitchell RalesDirector, since 1983
- Mr. Greg MilosevichExecutive Vice President
- Mr. Christopher RileyExecutive Vice President
- Ms. Julie Sawyer MontgomeryExecutive Vice President
- Dr. Jose-Carlos Gutierrez-RamosSenior Vice President, Chief Science Officer$7.5m
- Ms. Georgeann CoucharaSenior Vice President - Human Resources$5.3m
- Mr. Brian EllisSenior Vice President$5.0m
- Mr. R. Bradley GraySenior Vice President - Strategic Development
- Mr. Daniel RaskasSenior Vice President - Corporate Development
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 93
- Environment
- 99
- Social
- 99
- Governance
- 80
- Direct emissions (scope 1)
- 109,046 t
- Energy emissions (scope 2)
- 202,934 t
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Strong Global Presence: Danaher Corp operates in various countries worldwide, allowing it to tap into diverse markets and benefit from global growth opportunities.
- Diverse Product Portfolio: The company offers a broad range of products, spanning multiple industries such as life sciences, diagnostics, and environmental and applied solutions. This diversification reduces reliance on a single sector and mitigates risks.
- Focus on Innovation: Danaher Corp emphasizes research and development, continually introducing new and innovative solutions to meet evolving customer needs. This helps maintain a competitive edge in the market.
Weaknesses
- Dependency on Acquisitions: Danaher Corp has relied heavily on acquisitions for growth, which can pose integration challenges and increase financial risks if not managed effectively.
- Limited Brand Recognition: The company's brand awareness among consumers may be relatively low compared to its competitors, potentially hampering customer loyalty and market penetration.
- Vulnerability to Economic Fluctuations: As a global company, Danaher Corp is susceptible to economic downturns and fluctuations in different markets, which can impact its financial performance.
Opportunities
- Growing Demand for Healthcare Solutions: The increasing focus on healthcare and life sciences presents opportunities for Danaher Corp to further expand its product offerings in these sectors and capitalize on the rising demand.
- Technological Advancements: Advancements in technology open doors for the development of new and improved products, providing Danaher Corp with opportunities to innovate and stay ahead of competitors.
- Emerging Markets: The company can tap into emerging markets, especially in Asia and Latin America, where there is significant potential for growth due to increasing industrialization and economic development.
Threats
- Intense Competition: Danaher Corp faces intense competition from both established players and emerging companies in its various sectors. This competition can erode market share and profitability.
- Regulatory Changes: Changes in regulations, particularly in the healthcare and environmental sectors, can impact the company's operations and necessitate compliance costs, adding operational challenges.
- Currency Exchange Rate Fluctuations: As a global company, Danaher Corp is exposed to currency exchange rate fluctuations, which can affect its financial results and profitability when converting revenues into different currencies.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.